[Model of therapeutic programming in NIDDM diabetes]

Area of Science:

• Endocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Current non-insulin-dependent diabetes mellitus (NIDDM) treatment selection relies on empirical glycemic profiles.
• There is a need for laboratory-based methods to optimize diabetes management and restore metabolic equilibrium efficiently.

Purpose of the Study:

• To develop and validate a laboratory-based method for assessing diabetes severity and guiding therapeutic choices.
• To propose sensitivity tests for sulfonylureas (SU) and insulin to determine optimal drug selection and dosage.

Main Methods:

• Assessing diabetes severity using mean daily glucose concentrations and standard deviation for instability.
• Implementing a sulfonylurea (SU) sensitivity test to guide therapy selection.
• Utilizing an insulin sensitivity test to determine optimal insulin dosage.

Main Results:

• The SU sensitivity test's effectiveness is independent of diabetes severity.
• The SU test demonstrates high positive predictive value (sensitivity) for treatment selection.
• Analysis revealed a high percentage of patients receiving inadequate therapy when treatment decisions deviated from sensitivity test recommendations.

Conclusions:

• Laboratory-based sensitivity tests can significantly improve the accuracy of NIDDM treatment selection and dosage.
• This approach offers a more objective and potentially efficacious method for managing diabetes compared to empirical treatment adjustments.
• Implementing validated sensitivity tests can reduce instances of incorrect therapy type or dosage, leading to better patient outcomes.